Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 93

1.

The prevention of colitis-related cancer by 5-aminosalicylates: an appealing hypothesis that remains unproven.

Terdiman JP.

Am J Gastroenterol. 2011 Apr;106(4):737-40. doi: 10.1038/ajg.2011.56.

PMID:
21468069
[PubMed - indexed for MEDLINE]
2.

[5-aminosalicylates and colorectal cancer: preventive role in chronic inflammatory bowel disease?].

Desreumaux P, Romano O.

Gastroenterol Clin Biol. 2004 May;28(5):509. French. No abstract available.

PMID:
15243337
[PubMed - indexed for MEDLINE]
Free Article
3.

The role of chemoprevention of colorectal cancer with 5-aminosalicylates in ulcerative colitis.

Herfarth H.

Dig Dis. 2012;30 Suppl 2:55-9. doi: 10.1159/000341894. Epub 2012 Nov 23. Review.

PMID:
23207933
[PubMed - indexed for MEDLINE]
4.

Cancer prevention in inflammatory bowel disease and the chemoprophylactic potential of 5-aminosalicylic acid.

Bernstein CN, Eaden J, Steinhart AH, Munkholm P, Gordon PH.

Inflamm Bowel Dis. 2002 Sep;8(5):356-61. Review.

PMID:
12479651
[PubMed - indexed for MEDLINE]
5.

Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates.

Munkholm P, Loftus EV Jr, Reinacher-Schick A, Kornbluth A, Mittmann U, Esendal B.

Digestion. 2006;73(1):11-9. Epub 2006 Jan 10. Review.

PMID:
16410688
[PubMed - indexed for MEDLINE]
6.

[5-aminosalicylic acid and cancer prophylaxis?].

Thomsen OO.

Ugeskr Laeger. 2006 May 22;168(21):2047. Danish. No abstract available.

PMID:
16768920
[PubMed - indexed for MEDLINE]
7.

Effect of 5-aminosalicylate use on colorectal cancer and dysplasia risk: a systematic review and metaanalysis of observational studies.

Velayos FS, Terdiman JP, Walsh JM.

Am J Gastroenterol. 2005 Jun;100(6):1345-53.

PMID:
15929768
[PubMed - indexed for MEDLINE]
8.

[Mesalazine in ulcerative colitis. Fewer cases of colorectal carcinoma].

[No authors listed]

MMW Fortschr Med. 2002 Feb 28;144(9):51. German. No abstract available.

PMID:
11921656
[PubMed - indexed for MEDLINE]
9.

Chemoprevention of colorectal neoplasia in ulcerative colitis: the effect of 6-mercaptopurine.

Allgayer H, Kruis W.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):521; author reply 521. No abstract available.

PMID:
16616360
[PubMed - indexed for MEDLINE]
10.

[Primary chemoprevention of colorectal cancer in patients with inflammatory bowel diseases].

Ioffe AIu.

Lik Sprava. 2005 Jun;(4):45-8. Russian.

PMID:
16158715
[PubMed - indexed for MEDLINE]
11.

How long is it advisable to prolong maintenance treatment of patients with ulcerative colitis?

Ardizzone S, Porro GB.

Inflamm Bowel Dis. 2008 Oct;14 Suppl 2:S238-9. doi: 10.1002/ibd.20671. No abstract available. Erratum in: Inflamm Bowel Dis. 2009 Sep;15(9):1438-47.

PMID:
18816705
[PubMed - indexed for MEDLINE]
12.

[Medical therapy of inflammatory bowel diseases: ulcerative colitis].

Lakatos L, Lakatos PL.

Orv Hetil. 2007 Jun 24;148(25):1163-70. Review. Hungarian.

PMID:
17573252
[PubMed - indexed for MEDLINE]
13.

5-Aminosalicylic acid therapy and the risk of colorectal cancer among patients with inflammatory bowel disease.

Terdiman JP, Steinbuch M, Blumentals WA, Ullman TA, Rubin DT.

Inflamm Bowel Dis. 2007 Apr;13(4):367-71.

PMID:
17206695
[PubMed - indexed for MEDLINE]
14.

Progression to colorectal neoplasia in ulcerative colitis: effect of mesalamine.

Ullman T, Croog V, Harpaz N, Hossain S, Kornbluth A, Bodian C, Itzkowitz S.

Clin Gastroenterol Hepatol. 2008 Nov;6(11):1225-30; quiz 1177. doi: 10.1016/j.cgh.2008.05.020. Epub 2008 Oct 9.

PMID:
18848502
[PubMed - indexed for MEDLINE]
15.

Role of 5-aminosalicylate in preventing colorectal cancer.

Riyaz S, Hamlin J, Everett S.

Am J Gastroenterol. 2011 Sep;106(9):1720-1; author reply 1721-2. doi: 10.1038/ajg.2011.205. No abstract available.

PMID:
21897414
[PubMed - indexed for MEDLINE]
16.

[Colorectal cancer in inflammatory bowel disease].

Henriksen M, Moum B.

Tidsskr Nor Laegeforen. 2007 Oct 18;127(20):2696-9. Review. Norwegian.

PMID:
17952155
[PubMed - indexed for MEDLINE]
Free Article
17.

Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.

Ryan BM, Russel MG, Langholz E, Stockbrugger RW.

Am J Gastroenterol. 2003 Aug;98(8):1682-7. Review.

PMID:
12907319
[PubMed - indexed for MEDLINE]
18.

Controversies with aminosalicylates in inflammatory bowel disease.

Lim WC, Hanauer SB.

Rev Gastroenterol Disord. 2004 Summer;4(3):104-17. Review.

PMID:
15359211
[PubMed - indexed for MEDLINE]
19.

[Chronic inflammatory bowel diseases. Recurrence prevention = carcinoma prevention?].

Vetter C.

MMW Fortschr Med. 2005 Mar 31;147(13):10. German. No abstract available.

PMID:
15832752
[PubMed - indexed for MEDLINE]
20.

Mesalamine protects against colorectal cancer in inflammatory bowel disease.

Tang J, Sharif O, Pai C, Silverman AL.

Dig Dis Sci. 2010 Jun;55(6):1696-703. doi: 10.1007/s10620-009-0942-x. Epub 2009 Aug 25.

PMID:
19705280
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk